JP7297739B2 - 脂肪組織製品および製造方法 - Google Patents

脂肪組織製品および製造方法 Download PDF

Info

Publication number
JP7297739B2
JP7297739B2 JP2020514959A JP2020514959A JP7297739B2 JP 7297739 B2 JP7297739 B2 JP 7297739B2 JP 2020514959 A JP2020514959 A JP 2020514959A JP 2020514959 A JP2020514959 A JP 2020514959A JP 7297739 B2 JP7297739 B2 JP 7297739B2
Authority
JP
Japan
Prior art keywords
tissue
matrix
product composition
tissue product
adipose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020514959A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500091A5 (https=
JP2021500091A (ja
Inventor
シュ，フゥイ
ファン，キャリー
シャー，ミリナル
ジェソップ，イスラエル，ジェイムズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeCell Corp
Original Assignee
LifeCell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeCell Corp filed Critical LifeCell Corp
Publication of JP2021500091A publication Critical patent/JP2021500091A/ja
Publication of JP2021500091A5 publication Critical patent/JP2021500091A5/ja
Priority to JP2023097529A priority Critical patent/JP7559144B2/ja
Application granted granted Critical
Publication of JP7297739B2 publication Critical patent/JP7297739B2/ja
Priority to JP2024160651A priority patent/JP7785886B2/ja
Priority to JP2025225787A priority patent/JP2026062652A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/04—Materials or treatment for tissue regeneration for mammary reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
JP2020514959A 2017-10-18 2018-10-18 脂肪組織製品および製造方法 Active JP7297739B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2023097529A JP7559144B2 (ja) 2017-10-18 2023-06-14 脂肪組織製品および製造方法
JP2024160651A JP7785886B2 (ja) 2017-10-18 2024-09-18 脂肪組織製品および製造方法
JP2025225787A JP2026062652A (ja) 2017-10-18 2025-12-03 脂肪組織製品および製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762573892P 2017-10-18 2017-10-18
US62/573,892 2017-10-18
PCT/US2018/056473 WO2019079570A1 (en) 2017-10-18 2018-10-18 ADIPOSE TISSUE PRODUCTS AND METHODS OF PRODUCTION

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023097529A Division JP7559144B2 (ja) 2017-10-18 2023-06-14 脂肪組織製品および製造方法

Publications (3)

Publication Number Publication Date
JP2021500091A JP2021500091A (ja) 2021-01-07
JP2021500091A5 JP2021500091A5 (https=) 2021-12-16
JP7297739B2 true JP7297739B2 (ja) 2023-06-26

Family

ID=64267918

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020514959A Active JP7297739B2 (ja) 2017-10-18 2018-10-18 脂肪組織製品および製造方法
JP2023097529A Active JP7559144B2 (ja) 2017-10-18 2023-06-14 脂肪組織製品および製造方法
JP2024160651A Active JP7785886B2 (ja) 2017-10-18 2024-09-18 脂肪組織製品および製造方法
JP2025225787A Pending JP2026062652A (ja) 2017-10-18 2025-12-03 脂肪組織製品および製造方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2023097529A Active JP7559144B2 (ja) 2017-10-18 2023-06-14 脂肪組織製品および製造方法
JP2024160651A Active JP7785886B2 (ja) 2017-10-18 2024-09-18 脂肪組織製品および製造方法
JP2025225787A Pending JP2026062652A (ja) 2017-10-18 2025-12-03 脂肪組織製品および製造方法

Country Status (7)

Country Link
US (3) US10821205B2 (https=)
EP (2) EP4541385A3 (https=)
JP (4) JP7297739B2 (https=)
CN (2) CN115252910A (https=)
AU (3) AU2018351051A1 (https=)
CA (1) CA3075099A1 (https=)
WO (1) WO2019079570A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016001247A (es) 2013-07-30 2016-08-17 Musculoskeletal Transplant Foundation Matrices derivadas de tejido suave acelular y metodos para preparar las mismas.
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
WO2019079570A1 (en) * 2017-10-18 2019-04-25 Lifecell Corporation ADIPOSE TISSUE PRODUCTS AND METHODS OF PRODUCTION
WO2019079672A1 (en) 2017-10-19 2019-04-25 Lifecell Corporation ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
ES3056561T3 (en) * 2019-05-30 2026-02-23 Lifecell Corp Biologic breast implant
WO2021003321A1 (en) * 2019-07-03 2021-01-07 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US20210052774A1 (en) * 2019-08-21 2021-02-25 Lifecell Corporation Fixed-shape tissue matrix and related methods
KR102433259B1 (ko) * 2019-12-17 2022-08-17 주식회사 엘앤씨바이오 지방조직 유래 세포외기질을 포함하는 의료용 조성물 및 그 제조방법
WO2021125373A1 (ko) * 2019-12-17 2021-06-24 주식회사 엘앤씨바이오 지방조직 유래 세포외기질을 포함하는 의료용 조성물 및 그 제조방법
EP4233897A4 (en) * 2020-10-23 2024-10-02 SK Bioscience Co., Ltd. Vaccine composition or kit for reducing size or volume of target tissue, containing genetic material that encodes foreign antigen
EP4052734B1 (en) * 2021-03-02 2024-04-24 Solidified Inc. Immunocompatible tissue scaffold and methods of forming the same
US12351620B1 (en) 2023-05-03 2025-07-08 Humabiologics, Inc. Process for production of a soluble and insoluble collagen product from mammalian dermis tissue
US12351621B1 (en) 2023-05-03 2025-07-08 Humabiologics, Inc. Composite collagen product and method of making thereof
US12134792B1 (en) 2023-05-03 2024-11-05 Humabiologics, Inc. Process for production of a soluble and insoluble collagen product from mammalian dermis tissue

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003017826A2 (en) 2001-08-27 2003-03-06 Regeneration Technologies, Inc. Processed soft tissue for topical or internal application
JP2014512232A (ja) 2011-04-21 2014-05-22 サイトグラフ ティッシュ エンジニアリング インコーポレイテッド 細胞合成粒子
JP2016527338A (ja) 2013-06-11 2016-09-08 アンティース ソシエテ アノニム ヒアルロン酸の架橋方法；注射用ハイドロゲルの調製方法；得られるハイドロゲル；得られるハイドロゲルの使用
JP2017529164A (ja) 2014-09-25 2017-10-05 アセル，インコーポレイテッド 細胞外マトリックス由来の多孔質フォーム、多孔質フォームｅｃｍ医療装置、並びに、それらの使用及び製造方法

Family Cites Families (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1562244A (en) 1976-11-11 1980-03-05 Lock P M Wound dressing materials
US4569348A (en) 1980-02-22 1986-02-11 Velcro Usa Inc. Catheter tube holder strap
US4373519A (en) 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
IL74715A0 (en) 1984-03-27 1985-06-30 Univ New Jersey Med Biodegradable matrix and methods for producing same
US4969912A (en) 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
CA2002261A1 (en) 1988-11-07 1990-05-07 Andreas Sommer High molecular weight human angiogenic factors
JP2719671B2 (ja) 1989-07-11 1998-02-25 日本ゼオン株式会社 創傷被覆材
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5131850A (en) 1989-11-03 1992-07-21 Cryolife, Inc. Method for cryopreserving musculoskeletal tissues
US5104957A (en) 1990-02-28 1992-04-14 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
US8067149B2 (en) 1990-09-12 2011-11-29 Lifecell Corporation Acellular dermal matrix and method of use thereof for grafting
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
CA2051092C (en) 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
US5231169A (en) 1990-10-17 1993-07-27 Norian Corporation Mineralized collagen
US5263971A (en) 1991-02-13 1993-11-23 Life Medical Sciences, Inc. Apparatus for the closure of wide skin defects by stretching of skin
US5254133A (en) 1991-04-24 1993-10-19 Seid Arnold S Surgical implantation device and related method of use
US5149331A (en) 1991-05-03 1992-09-22 Ariel Ferdman Method and device for wound closure
US5160313A (en) 1991-05-14 1992-11-03 Cryolife, Inc. Process for preparing tissue for transplantation
US7198046B1 (en) 1991-11-14 2007-04-03 Wake Forest University Health Sciences Wound treatment employing reduced pressure
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5641518A (en) 1992-11-13 1997-06-24 Purdue Research Foundation Method of repairing bone tissue
US5437651A (en) 1993-09-01 1995-08-01 Research Medical, Inc. Medical suction apparatus
US5549584A (en) 1994-02-14 1996-08-27 The Kendall Company Apparatus for removing fluid from a wound
ATE265191T1 (de) 1994-03-14 2004-05-15 Cryolife Inc Herstellungsverfahren von gewebe zur implantation
US5489304A (en) 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US5599852A (en) 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
US5622867A (en) 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
US6485723B1 (en) 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US5834232A (en) 1996-05-01 1998-11-10 Zymogenetics, Inc. Cross-linked gelatin gels and methods of making them
US6666892B2 (en) 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) * 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6998418B1 (en) 1996-11-05 2006-02-14 Gp Medical, Inc. Acellular biological material chemically treated with genipin
US6096347A (en) 1996-11-05 2000-08-01 Purdue Research Foundation Myocardial graft constructs
AUPO599897A0 (en) 1997-04-03 1997-05-01 Vidal, Linus Clear collagen for facial implants
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US6135116A (en) 1997-07-28 2000-10-24 Kci Licensing, Inc. Therapeutic method for treating ulcers
US6613278B1 (en) 1998-11-13 2003-09-02 Regeneration Technologies, Inc. Tissue pooling process
GB9719520D0 (en) 1997-09-12 1997-11-19 Kci Medical Ltd Surgical drape and suction heads for wound treatment
US6371992B1 (en) 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
US6326018B1 (en) 1998-02-27 2001-12-04 Musculoskeletal Transplant Foundation Flexible sheet of demineralized bone
US20030039678A1 (en) 1998-03-16 2003-02-27 Stone Kevin R. Xenograft bone matrix for orthopedic applications
US6179872B1 (en) 1998-03-17 2001-01-30 Tissue Engineering Biopolymer matt for use in tissue repair and reconstruction
US6432710B1 (en) 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
JP2002516254A (ja) 1998-05-26 2002-06-04 ライフセル コーポレイション ヒト赤血球の低温保存
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
CA2335686C (en) 1998-06-19 2008-11-18 Lifecell Corporation Particulate acellular tissue matrix
WO2000016822A1 (en) 1998-09-21 2000-03-30 The Brigham And Women's Hospital, Inc. Compositions and methods for tissue repair
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
WO2000047114A1 (en) 1999-02-12 2000-08-17 Collagenesis, Inc. Injectable collagen-based delivery system for bone morphogenic proteins
US6856821B2 (en) 2000-05-26 2005-02-15 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US6599318B1 (en) 1999-11-30 2003-07-29 Shlomo Gabbay Implantable support apparatus and method of using same
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
MXPA03002414A (es) 2000-09-18 2004-07-08 Organogenesis Inc Protesis con injerto de hoja plana tratada por bioingenieria y su uso.
IL139708A0 (en) 2000-11-15 2002-02-10 Amiel Gilad Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
US7070584B2 (en) 2001-02-20 2006-07-04 Kci Licensing, Inc. Biocompatible wound dressing
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
JP4451658B2 (ja) 2001-10-18 2010-04-14 ライフセル コーポレーション 組織および器官のリモデリング
WO2003072157A1 (en) 2002-02-21 2003-09-04 Encelle, Inc. Immobilized bioactive hydrogel matrices as surface coatings
WO2003080119A1 (en) 2002-03-26 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Responsive biomedical composites
US20030225347A1 (en) 2002-06-03 2003-12-04 Argenta Louis C. Directed tissue growth employing reduced pressure
US7498040B2 (en) 2005-10-12 2009-03-03 Lifenet Health Compositions for repair of defects in osseous tissues, and methods of making the same
US20040037735A1 (en) 2002-08-23 2004-02-26 Depaula Carl Alexander Allograft tissue purification process for cleaning bone
US6840960B2 (en) 2002-09-27 2005-01-11 Stephen K. Bubb Porous implant system and treatment method
US7402319B2 (en) 2002-09-27 2008-07-22 Board Of Regents, The University Of Texas System Cell-free tissue replacement for tissue engineering
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US7115100B2 (en) 2002-11-15 2006-10-03 Ethicon, Inc. Tissue biopsy and processing device
FR2856305B1 (fr) 2003-06-19 2007-08-24 Inst Nat Sante Rech Med Protheses avec revetements biologiquement actifs
EP2399990B1 (en) 2003-06-27 2015-07-22 DePuy Synthes Products, Inc. Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system
WO2005009134A1 (en) 2003-07-21 2005-02-03 Lifecell Corporation ACELLULAR TISSUE MATRICES MADE FROM GALACTOSE α-1,3-GALACTOSE-DEFICIENT TISSUE
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
CN104721883A (zh) 2004-03-17 2015-06-24 雷维维科公司 来源于缺乏任何功能性α1,3半乳糖基转移酶表达的动物的组织产品
KR100680134B1 (ko) 2004-06-10 2007-02-08 박우삼 무세포 진피를 주사가능하도록 입자 형태로 가공한 필러
US20060058892A1 (en) 2004-09-16 2006-03-16 Lesh Michael D Valved tissue augmentation implant
US20060073592A1 (en) 2004-10-06 2006-04-06 Wendell Sun Methods of storing tissue matrices
US7905826B2 (en) 2004-11-03 2011-03-15 Cook Incorporated Methods for modifying vascular vessel walls
DE102005002644A1 (de) 2005-01-19 2006-07-20 Schülke & Mayr GmbH Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung
CA2604856A1 (en) 2005-04-25 2006-11-02 Eric F. Bernstein Dermal fillers for biomedical applications in mammals and methods of using the same
ES2668551T3 (es) 2005-09-26 2018-05-18 Lifecell Corporation Composición seca de plaquetas
US7498041B2 (en) 2005-10-12 2009-03-03 Lifenet Health Composition for repair of defects in osseous tissues
JP5002805B2 (ja) 2005-10-14 2012-08-15 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
US8029498B2 (en) 2006-03-14 2011-10-04 Kci Licensing Inc. System for percutaneously administering reduced pressure treatment using balloon dissection
US9456860B2 (en) 2006-03-14 2016-10-04 Kci Licensing, Inc. Bioresorbable foaming tissue dressing
US20070248575A1 (en) 2006-04-19 2007-10-25 Jerome Connor Bone graft composition
EP2722425B1 (en) 2006-04-24 2016-01-20 Coloplast A/S Gelatin non-woven structures produced by a non-toxic dry solvent spinning process
ES2720582T3 (es) 2006-05-09 2019-07-23 Lifecell Corp Tejido biológico reforzado
JP5050197B2 (ja) 2006-07-31 2012-10-17 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
SG175690A1 (en) 2006-11-09 2011-11-28 Kci Licensing Inc Porous bioresorbable dressing conformable to a wound and methods of making same
JP5385257B2 (ja) * 2007-03-26 2014-01-08 バクスター・インターナショナル・インコーポレイテッド 軟部組織増強のための注入可能な空隙の充填剤
CA2685048A1 (en) 2007-04-26 2008-11-06 Advanced Technologies And Regenerative Medicine, Llc Tissue engineering devices and methods for luminal organs
US9034367B2 (en) 2007-05-10 2015-05-19 Cormatrix Cardiovascular, Inc. Articles for tissue regeneration with biodegradable polymer
RU2447878C2 (ru) 2007-06-29 2012-04-20 КейСиАй Лайсензинг Инк. Активация образования костей и хрящей
JP5538217B2 (ja) 2007-07-10 2014-07-02 ライフセル コーポレーション 組織修復用無細胞組織基質構成体
US20090024224A1 (en) 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
CN101161298A (zh) * 2007-11-20 2008-04-16 郑隆泗 一种以明胶为原料制备明胶海绵颗粒栓塞剂的工艺
US9161970B2 (en) * 2007-12-12 2015-10-20 Allergan, Inc. Dermal filler
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
US8372060B2 (en) 2008-05-13 2013-02-12 Kci Licensing, Inc. Catheter/filament style device and methods for treatment of wounds beneath the surface of the skin
CA2726350C (en) 2008-06-06 2016-07-19 Lifecell Corporation Elastase treatment of tissue matrices
TW201000162A (en) 2008-06-25 2010-01-01 Kci Licensing Inc Absorbable, reduced-pressure manifolds and systems
WO2009158480A2 (en) 2008-06-26 2009-12-30 Kci Licensing, Inc. Stimulation of cartilage formation using reduced pressure treatment
EP3744357A1 (en) 2008-08-14 2020-12-02 3M Innovative Properties Company Tissue scaffolds
US7927414B2 (en) 2008-09-05 2011-04-19 Ethicon, Inc. Method of manufacturing acellular matrix glue
JP5784500B2 (ja) 2008-11-21 2015-09-24 ライフセル コーポレーションＬｉｆｅＣｅｌｌ Ｃｏｒｐｏｒａｔｉｏｎ 強化型生物由来物質
WO2010078353A2 (en) 2008-12-31 2010-07-08 Kci Licensing, Inc. Systems for providing fluid flow to tissues
WO2010078358A2 (en) 2008-12-31 2010-07-08 Kcl Licensing, Inc. Systems for inducing fluid flow to stimulate tissue growth
KR20110102921A (ko) 2008-12-31 2011-09-19 케이씨아이 라이센싱 인코포레이티드 조직 롤 스캐폴드
US20110020271A1 (en) 2009-05-20 2011-01-27 Humacyte, Inc. Elastin for soft tissue augmentation
CN101574539B (zh) * 2009-06-15 2012-07-18 北京大学 一种明胶海绵及其制备方法
CA2770490C (en) 2009-08-11 2024-04-16 The Johns Hopkins University Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
MX2012006759A (es) * 2009-12-17 2012-07-30 Univ Kingston Tejido adiposo descelularizado.
JP5818372B2 (ja) 2010-01-22 2015-11-18 ケーシーアイ ライセンシング インク 陰圧創傷療法に関する発泡流体灌注デバイス、システムおよび方法
US8632512B2 (en) 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US9636435B2 (en) 2010-07-08 2017-05-02 Lifecell Corporation Method for shaping tissue matrices
ES2662331T3 (es) 2010-08-10 2018-04-06 Lifecell Corporation Matrices tisulares regenerativas
CN101991875B (zh) * 2010-10-29 2014-01-22 上海昊海生物科技股份有限公司 介孔生物活性玻璃和壳聚糖复合多孔止血材料及制备方法
CN102068714A (zh) * 2011-01-19 2011-05-25 北京大学 一种胶原海绵及其制备方法
CA2832838C (en) 2011-04-14 2019-08-13 Lifecell Corporation Regenerative tissue matrix flakes
AU2012262311B2 (en) * 2011-05-31 2016-04-28 Lifecell Corporation Adipose tissue matrices
MX353955B (es) 2011-10-11 2018-02-07 Allergan Holdings France Sas Hebras de acido hialuronico reticulado y metodos de uso de las mismas.
CA2890366A1 (en) 2011-11-09 2013-05-16 Trustees Of Tufts College Injectable silk fibroin particles and uses thereof
US20130121970A1 (en) * 2011-11-10 2013-05-16 Lifecell Corporation Method for elimination of space through tissue approximation
ES2729712T3 (es) 2011-12-20 2019-11-05 Lifecell Corp Productos de tejido de lámina
WO2013096252A1 (en) 2011-12-20 2013-06-27 Lifecell Corporation Flowable tissue products
US9999637B2 (en) 2012-04-24 2018-06-19 Lifecell Corporation Functionalized tissue matrices
AU2013251800B2 (en) 2012-04-24 2016-09-29 Lifecell Corporation Flowable tissue matrices
WO2014144215A1 (en) 2013-03-15 2014-09-18 The Board Of Trustees Of The Leland Stanford Junior University Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use
WO2015048317A1 (en) 2013-09-25 2015-04-02 The Children's Mercy Hospital Decellularized hyaline cartilage powder for tissue scaffolds
KR101729127B1 (ko) * 2014-10-24 2017-04-26 주식회사 엘앤씨바이오 입자형 무세포 진피와 히알루론산이 전자빔을 통해 물리적으로 가교된 생체 이식용 조성물의 제조방법
US20170021058A1 (en) * 2015-07-24 2017-01-26 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
GB201514788D0 (en) * 2015-08-20 2015-10-07 Ecole Polytech Malleable scaffold material and uses thereof
CA3012849A1 (en) 2016-02-08 2017-08-17 Lifecell Corporation Biologic breast implant
WO2019079570A1 (en) * 2017-10-18 2019-04-25 Lifecell Corporation ADIPOSE TISSUE PRODUCTS AND METHODS OF PRODUCTION
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
WO2019079672A1 (en) 2017-10-19 2019-04-25 Lifecell Corporation ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003017826A2 (en) 2001-08-27 2003-03-06 Regeneration Technologies, Inc. Processed soft tissue for topical or internal application
JP2014512232A (ja) 2011-04-21 2014-05-22 サイトグラフ ティッシュ エンジニアリング インコーポレイテッド 細胞合成粒子
JP2016527338A (ja) 2013-06-11 2016-09-08 アンティース ソシエテ アノニム ヒアルロン酸の架橋方法；注射用ハイドロゲルの調製方法；得られるハイドロゲル；得られるハイドロゲルの使用
JP2017529164A (ja) 2014-09-25 2017-10-05 アセル，インコーポレイテッド 細胞外マトリックス由来の多孔質フォーム、多孔質フォームｅｃｍ医療装置、並びに、それらの使用及び製造方法

Also Published As

Publication number Publication date
EP4541385A2 (en) 2025-04-23
US10821205B2 (en) 2020-11-03
WO2019079570A1 (en) 2019-04-25
JP2026062652A (ja) 2026-04-10
CN111201046A (zh) 2020-05-26
AU2018351051A1 (en) 2020-03-19
JP2025011092A (ja) 2025-01-23
AU2025263895A1 (en) 2025-12-04
EP4541385A3 (en) 2025-06-25
US20250065018A1 (en) 2025-02-27
CN115252910A (zh) 2022-11-01
AU2024205150A1 (en) 2024-08-15
CA3075099A1 (en) 2019-04-25
EP3697460A1 (en) 2020-08-26
CN111201046B (zh) 2022-06-28
JP7785886B2 (ja) 2025-12-15
JP2023123578A (ja) 2023-09-05
US20210038767A1 (en) 2021-02-11
JP7559144B2 (ja) 2024-10-01
US20190111183A1 (en) 2019-04-18
JP2021500091A (ja) 2021-01-07

Similar Documents

Publication Publication Date Title
JP7559144B2 (ja) 脂肪組織製品および製造方法
US11123375B2 (en) Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US20240226375A1 (en) Flowable acellular tissue matrix products and methods of production
US20230211048A1 (en) Biologic breast implant
WO2021003321A1 (en) Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
WO2021202965A1 (en) Adipose tissue matrix with tropoelastin

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211015

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211015

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220920

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230208

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230516

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230614

R150 Certificate of patent or registration of utility model

Ref document number: 7297739

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150